A. J. Kazimi - 01 Dec 2025 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
01 Dec 2025
Net transactions value
+$799
Form type
4
Filing time
06 Jan 2026, 17:03:52 UTC
Previous filing
01 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KAZIMI A J Chairman and CEO, Director, 10%+ Owner 1600 WEST END AVE., SUITE 1300, NASHVILLE A.J. Kazimi by /s/ John Hamm as attorney-in-fact 06 Jan 2026 0001075050

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $42.48 +18 +0% $2.36 5,700,903 01 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $40.32 +18 +0% $2.24 5,700,921 02 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $40.5 +18 +0% $2.25 5,700,939 03 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $40.86 +18 +0% $2.27 5,700,957 04 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $42.12 +18 +0% $2.34 5,700,975 05 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $33.6 +14 +0% $2.40 5,700,989 08 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $32.48 +14 +0% $2.32 5,701,003 09 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $36.4 +14 +0% $2.60 5,701,017 10 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $35.84 +14 +0% $2.56 5,701,031 11 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $35 +14 +0% $2.50 5,701,045 12 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $39.48 +14 +0% $2.82 5,701,059 15 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $45.78 +14 +0% $3.27 5,701,073 16 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $36.5 +10 +0% $3.65 5,701,083 17 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $41.9 +10 +0% $4.19 5,701,093 18 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $33.52 +8 +0% $4.19 5,701,101 19 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $30.24 +7 +0% $4.32 5,701,108 22 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $33.04 +8 +0% $4.13 5,701,116 23 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $34.08 +8 +0% $4.26 5,701,124 24 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $33.68 +8 +0% $4.21 5,701,132 26 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $32.08 +8 +0% $4.01 5,701,140 29 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $31.52 +8 +0% $3.94 5,701,148 30 Dec 2025 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $27.37 +7 +0% $3.91 5,701,155 31 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.